Market Indices
Sector Heatmap
BBIO — BridgeBio Pharma, Inc. Common Stock
NasdaqBridgeBio Pharma, Inc. Common Stock
- O
- 67.10
- H
- 68.68
- L
- 66.23
- V
- 2.65M
BBIO — Latest News & Headlines
14 StoriesWhy BridgeBio Pharma (BBIO) Stock Is Down Today - Quiver Quantitative
Why BridgeBio Pharma (BBIO) Stock Is Down Today Quiver Quantitative
BridgeBio Pharma (BBIO) Stock Looks Properly Priced For Its Sales Story - Simply Wall Street
BridgeBio Pharma (BBIO) Stock Looks Properly Priced For Its Sales Story Simply Wall Street
7 Red Days In A Row: BridgeBio Pharma Stock Is Down 12% - Trefis
7 Red Days In A Row: BridgeBio Pharma Stock Is Down 12% Trefis
BridgeBio (NASDAQ: BBIO) CEO’s trust sells 10,000 shares under preset plan - Stock Titan
BridgeBio (NASDAQ: BBIO) CEO’s trust sells 10,000 shares under preset plan Stock Titan
BridgeBio Pharma (BBIO) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
BridgeBio Pharma (BBIO) Short Interest & Short Float | Updated Sep 2026 MarketBeat
BBIO Oct 2026 65.000 call (BBIO261016C00065000) interactive stock chart - Yahoo Finance UK
BBIO Oct 2026 65.000 call (BBIO261016C00065000) interactive stock chart Yahoo Finance UK
(BBIO) Movement as an Input in Quant Signal Sets - Stock Traders Daily
(BBIO) Movement as an Input in Quant Signal Sets Stock Traders Daily
BridgeBio Pharma CEO Neil Kumar sells $690,847 in shares By Investing.com - Investing.com Canada
BridgeBio Pharma CEO Neil Kumar sells $690,847 in shares By Investing.com Investing.com Canada
BridgeBio Pharma Announces Real-World Study Showing Acoramidis Reduced Clinical Worsening Versus Tafamidis in ATTR-CM - Quiver Quantitative
BridgeBio Pharma Announces Real-World Study Showing Acoramidis Reduced Clinical Worsening Versus Tafamidis in ATTR-CM Quiver Quantitative
BridgeBio Pharma (BBIO) Following Acoramidis Study Faces A Wide Fair Value Debate - Simply Wall Street
BridgeBio Pharma (BBIO) Following Acoramidis Study Faces A Wide Fair Value Debate Simply Wall Street
BridgeBio Pharma stock finds support near USD 66 - AD HOC NEWS
BridgeBio Pharma stock finds support near USD 66 AD HOC NEWS
BBIO May 2027 90.000 call (BBIO270521C00090000) stock price, news, quote and history - Yahoo Finance Singapore
BBIO May 2027 90.000 call (BBIO270521C00090000) stock price, news, quote and history Yahoo Finance Singapore
Real World Heart Study Altering The Investment Case For BridgeBio Pharma Stock? - Simply Wall Street
Real World Heart Study Altering The Investment Case For BridgeBio Pharma Stock? Simply Wall Street
BridgeBio Pharma (BBIO) Reports 34% Lower Risk Of Early Clinical Worsening - Simply Wall Street
BridgeBio Pharma (BBIO) Reports 34% Lower Risk Of Early Clinical Worsening Simply Wall Street